An Australian medical cannabis company has raised $3.59 million ($5 million Australian) in an institutional placement, according to Business News of Australia.
The company – MMJ Phytotech, which develops medical cannabis pills, capsules and dosage regulators – unveiled the development on the same day it announced a $2.5 million loss in the last six months of 2015 on revenue of about $200,000.
The company hopes the capital infusion will help it break into the new market of Australia, which just recently legalized medical marijuana. The money will also help fund its subsidiary in Israel, which is planning to test cannabis capsules for treating pain and spasticity in patients who have multiple sclerosis.
